CMND Clearmind Medicine Inc.
Healthcare$2.26-8.13%ClosedMarket Cap: $2.3M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.32
P/S
0.00
EV/EBITDA
0.94
DCF Value
$1.03
FCF Yield
-299.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-211.9%
ROA
-69.2%
ROIC
-114.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-3.7M | $-3.9M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.0M | $-964.0K | $— | — |
| FY null | $0.00 | -Infinity% | $-5.7M | $-3.9M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-1.9M | $-1.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.8M | $-1.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.2M | $-1.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.2M | $-1.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-8.0M | $-7.3M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-2.0M | $-2.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.8M | $-1.2M | $— | — |
| Q1 2024 | $0.00 | -Infinity% | $-1.9M | $-1.8M | $-48.46 | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.4M | $-5.6M | $-629.05 | — |